These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 32329110)

  • 1. High affinity between CREBBP/p300 and NCOA evolved in vertebrates.
    Karlsson E; Lindberg A; Andersson E; Jemth P
    Protein Sci; 2020 Jul; 29(7):1687-1691. PubMed ID: 32329110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and dynamics conspire in the evolution of affinity between intrinsically disordered proteins.
    Jemth P; Karlsson E; Vögeli B; Guzovsky B; Andersson E; Hultqvist G; Dogan J; Güntert P; Riek R; Chi CN
    Sci Adv; 2018 Oct; 4(10):eaau4130. PubMed ID: 30397651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence and evolution of an interaction between intrinsically disordered proteins.
    Hultqvist G; Åberg E; Camilloni C; Sundell GN; Andersson E; Dogan J; Chi CN; Vendruscolo M; Jemth P
    Elife; 2017 Apr; 6():. PubMed ID: 28398197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the transition state for a binding reaction between ancient intrinsically disordered proteins.
    Karlsson E; Paissoni C; Erkelens AM; Tehranizadeh ZA; Sorgenfrei FA; Andersson E; Ye W; Camilloni C; Jemth P
    J Biol Chem; 2020 Dec; 295(51):17698-17712. PubMed ID: 33454008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disordered Regions Flanking the Binding Interface Modulate Affinity between CBP and NCOA.
    Karlsson E; Schnatwinkel J; Paissoni C; Andersson E; Herrmann C; Camilloni C; Jemth P
    J Mol Biol; 2022 Jul; 434(13):167643. PubMed ID: 35605677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping the interactions of adenoviral E1A proteins with the p160 nuclear receptor coactivator binding domain of CBP.
    Haberz P; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
    Protein Sci; 2016 Dec; 25(12):2256-2267. PubMed ID: 27699893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Charge Relaying within a Phospho-Motif Rescue Binding Competency of a Disordered Transcription Factor.
    McIvor JAP; Larsen DS; Mercadante D
    J Chem Inf Model; 2024 Aug; 64(15):6041-6052. PubMed ID: 39074869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of the interactions between the disordered Neh4 and Neh5 domains of Nrf2 and CBP/p300 in oxidative stress response.
    Karunatilleke NC; Brickenden A; Choy WY
    Protein Sci; 2024 Sep; 33(9):e5137. PubMed ID: 39150085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrinsically Disordered Flanking Regions Increase the Affinity of a Transcriptional Coactivator Interaction across Vertebrates.
    Karlsson E; Ottoson C; Ye W; Andersson E; Jemth P
    Biochemistry; 2023 Sep; 62(18):2710-2716. PubMed ID: 37647499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Selective CBP/P300 Benzoxazepine Bromodomain Inhibitors.
    Popp TA; Tallant C; Rogers C; Fedorov O; Brennan PE; Müller S; Knapp S; Bracher F
    J Med Chem; 2016 Oct; 59(19):8889-8912. PubMed ID: 27673482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic folding of two intrinsically disordered proteins: searching for conformational selection.
    Ganguly D; Zhang W; Chen J
    Mol Biosyst; 2012 Jan; 8(1):198-209. PubMed ID: 21766125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quasi-anharmonic analysis reveals intermediate states in the nuclear co-activator receptor binding domain ensemble.
    Burger VM; Ramanathan A; Savol AJ; Stanley CB; Agarwal PK; Chennubhotla CS
    Pac Symp Biocomput; 2012; ():70-81. PubMed ID: 22174264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Advances in the Development of CBP/p300 Bromodomain Inhibitors.
    Xiong Y; Zhang M; Li Y
    Curr Med Chem; 2020; 27(33):5583-5598. PubMed ID: 31364510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schistosoma mansoni CBP/p300 has a conserved domain structure and interacts functionally with the nuclear receptor SmFtz-F1.
    Bertin B; Oger F; Cornette J; Caby S; Noël C; Capron M; Fantappie MR; Rumjanek FD; Pierce RJ
    Mol Biochem Parasitol; 2006 Apr; 146(2):180-91. PubMed ID: 16427147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of the NCoA-1/SRC-1 PAS-B domain bound to the LXXLL motif of the STAT6 transactivation domain.
    Razeto A; Ramakrishnan V; Litterst CM; Giller K; Griesinger C; Carlomagno T; Lakomek N; Heimburg T; Lodrini M; Pfitzner E; Becker S
    J Mol Biol; 2004 Feb; 336(2):319-29. PubMed ID: 14757047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyzing S-adenosylhomocysteine hydrolase gene sequences in deuterostome genomes.
    Zhao JN; Wang Y; Zhao BS; Chen LL
    J Biomol Struct Dyn; 2009 Dec; 27(3):371-80. PubMed ID: 19795919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection and Application of DNA Aptamer Against Oncogene Amplified in Breast Cancer 1.
    An Y; Wu J; Yang B; Zhu Z; Gao M; Yu C; Yang CJ
    J Mol Evol; 2015 Dec; 81(5-6):179-85. PubMed ID: 26458993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Charge Interactions Can Dominate Coupled Folding and Binding on the Ribosome.
    Marino J; Buholzer KJ; Zosel F; Nettels D; Schuler B
    Biophys J; 2018 Sep; 115(6):996-1006. PubMed ID: 30173887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ancestral complement system in sea urchins.
    Smith LC; Clow LA; Terwilliger DP
    Immunol Rev; 2001 Apr; 180():16-34. PubMed ID: 11414357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential recognition of phosphorylated transactivation domains of p53 by different p300 domains.
    Polley S; Guha S; Roy NS; Kar S; Sakaguchi K; Chuman Y; Swaminathan V; Kundu T; Roy S
    J Mol Biol; 2008 Feb; 376(1):8-12. PubMed ID: 18155245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.